
Hematologist-Oncologist

No OPD information available
Chronic B-Cell Leukemia (CBCL)
Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Lymphoma (SLL)
Leukemia
Smith-Magenis Syndrome
Waldenstrom Macroglobulinemia
Ascites
Autoimmune Hemolytic Anemia
B-Cell Lymphoma
Chronic Familial Neutropenia
COVID-19
Mantle Cell Lymphoma (MCL)
Non-Hodgkin Lymphoma
Pemphigus
Pemphigus Foliaceus
Pemphigus Vulgaris
Pneumonia
Severe Acute Respiratory Syndrome (SARS)
Squamous Cell Skin Carcinoma
Stephen P. Mulligan is a male medical professional who helps patients with various health conditions like Chronic B-Cell Leukemia, Leukemia, and Pneumonia. He also specializes in treating diseases such as Smith-Magenis Syndrome and Non-Hodgkin Lymphoma.
Stephen P. Mulligan uses his special skills and knowledge to provide care to patients with different illnesses. He stays updated with the latest medical research to offer the best treatments possible. Patients trust him because he communicates well and listens to their concerns.
Stephen P. Mulligan collaborates with other medical professionals to ensure patients receive comprehensive care. He values teamwork and works closely with colleagues to improve patient outcomes. His dedication to his work has positively impacted many lives by helping patients manage their health conditions effectively.
One of Stephen P. Mulligan's notable publications is "An ALPINE guide to covalent BTKis in CLL," which shows his expertise in treating Chronic Lymphocytic Leukemia. He has also been involved in clinical trials, such as the study comparing the efficacy of different treatments for Waldenström's Macroglobulinemia.
Overall, Stephen P. Mulligan is a compassionate and knowledgeable healthcare provider who goes above and beyond to help his patients. His commitment to staying informed about the latest medical advancements and his collaborative approach with colleagues make him a trusted and respected professional in the field of medicine.
Enrollment Status: Completed
Published: October 26, 2024
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
